tirzepatide news october 18 2025 A 72-week trial compared the two leading GLP-1 medications FDA Says Shortage of GLP-1

Choose your workflow path and assign ownership for each stage (intake logging, triage, provider review, messaging)

Semaglutide, also known by other brand names, is still making waves on the Internet even after years of FDA approval

JAMA Study comparing Semaglutide and Tirzepatide for Weight Loss Efficacy A recent study in JAMA Internal Medicine reveals that Tirzepatide may be more effective than Semaglutide in achieving significant weight loss for adults with overweight or obesity

Knowledge is power

Exceedingly short half-life (12 min) of GLP-1 limits its therapeutic applicability, and the implication of its new variants is under question

Ozempic v Wegovy c nhiu ngi gi "bt gim cn thn k" song chuyn gia cnh bo ri ro t tc dng ph.